RGEN Repligen

• None no insider bought on the open market
• $3.5M sold by 3 insiders outside a trading plan
• $11.8M sold by 3 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Olivier Loeillot CEO
   Planned sale
   $1M 5,535 shares at $187.29 11% of stake
   Traded Oct 5 Filed Oct 6
   ↗
3. Olivier Loeillot CEO
   Planned sale
   $2.5M 12,946 shares at $190.00 21% of stake
   Traded Sep 24 Filed Sep 25
   ↗
4. Olivier Loeillot CEO
   Planned sale
   $977K 5,426 shares at $180.00 10% of stake
   Traded Sep 21 Filed Sep 22
   ↗
5. Olivier Loeillot CEO
   Planned sale
   $504K 3,035 shares at $165.90 5.9% of stake
   Traded Sep 4 Filed Sep 8
   ↗
6. Olivier Loeillot CEO
   Planned sale
   $977K 5,426 shares at $180.00 9.1% of stake
   Traded Aug 20 Filed Aug 21
   ↗
7. Jason K Garland CFO
   Planned sale
   $80K 530 shares at $150.00 2.7% of stake
   Traded Jul 16 Filed Jul 17
   ↗
8. Jason K Garland CFO
   Planned sale
   $106K 733 shares at $145.00 3.6% of stake
   Traded Jun 25 Filed Jun 26
   ↗
9. Olivier Loeillot CEO
   Planned sale
   $536K 3,832 shares at $140.00 6.6% of stake
   Traded Apr 21 Filed Apr 22
   ↗
10. Karen A Dawes Director
    Sale
    $44K 275 shares at $161.00 0.3% of stake
    Traded Dec 17, 2025 Filed Dec 18, 2025
    ↗
11. Olivier Loeillot CEO
    Planned sale
    $1.2M 7,041 shares at $170.00 16% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025
    ↗
12. James Bylund COO
    Sale
    $331K 2,191 shares at $151.21 9.2% of stake
    Traded Nov 18, 2025 Filed Nov 19, 2025
    ↗
13. Anthony Hunt Director
    Sale
    $3.1M 20,000 shares at $154.61 20% of stake
    Traded Nov 13, 2025 Filed Nov 14, 2025
    ↗
14. Anthony Hunt Director
    Planned sale
    $3.9M 25,000 shares at $156.88 20% of stake
    Traded Nov 12, 2025 Filed Nov 13, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 stock grants, 17 share withholdings for taxes, 9 option exercises, and 1 other transaction.